{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:55:39Z","timestamp":1795020939196,"version":"4.10.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,9]]},"abstract":"<jats:p>Optic neuritis frequently occurs during the clinical course of multiple sclerosis (MS). In this condition, demyelination of the optic nerve occurs, which electrophysiologically causes a delay in P100 wave latency. Sensitive cholesterol homeostasis is critical for the formation of the myelin sheath and for myelin to become functionally mature. High-density lipoprotein (HDL) becomes dysfunctional under oxidative stress and plays an important role in the pathogenesis of MS. In this study, HDL levels of MS patients suffering from optic neuritis were compared with those of healthy individuals, and the relationship between pattern reversal visual evoked potential (PRVEP) P100 wave latency and HDL levels in patients with optic neuritis attacks was analyzed. PRVEP studies were performed in patients with MS who had an episode of optic neuritis, and P100 wave latencies were measured. Peripheral blood samples were collected from healthy participants and patients. Lipid levels and myeloperoxidase (MPO) and paraoxonase (PON) activities were measured, and the MPO\/PON ratio was then calculated. The lipid profiles and dysfunctional HDL levels in the healthy and patient groups were compared. Finally, the relationship between these parameters and the PRVEP-P100 wave latency was examined. Total cholesterol and low-density lipoprotein (LDL) levels were significantly higher in the patient group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.044; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.038, respectively). There was no statistically significant difference in HDL levels between groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.659). The distribution of MPO values was similar between groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.452). PON values were significantly lower, whereas the MPO\/PON ratios were significantly higher in the patient group than in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.025; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.028, respectively). A statistically significant positive correlation was found between the elevated MPO\/PON ratio, representing dysfunctional HDL, and both the mean and maximum PRVEP-P100 wave latencies (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, <jats:italic toggle=\"yes\">R<\/jats:italic>\u2005=\u20050.690; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001, <jats:italic toggle=\"yes\">R<\/jats:italic>\u2005=\u20050.815, respectively). A dysfunctional form of HDL may lead to poor deactivation of remyelination-limiting factors and may ultimately be associated with poor outcomes in optic neuritis.<\/jats:p>","DOI":"10.1097\/md.0000000000037115","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:49Z","timestamp":1707509269000},"page":"e37115","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between pattern reversal visual evoked potential P100 wave latency and dysfunctional HDL in patients with multiple sclerosis subjected to an optic neuritis attack: A case-control study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1245-7273","authenticated-orcid":false,"given":"Gonul","family":"Vural","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey"},{"name":"Department of Neurology, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiye","family":"Gumusyayla","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey"},{"name":"Department of Neurology, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Karakoyunlu Eren","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Barakli","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ankara City Hospital, Ankara, Turkey"},{"name":"Department of Neurology, Sungurlu State Hospital, Corum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Demir Unal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ankara City Hospital, Ankara, Turkey"},{"name":"Department of Neurology, Yenimahalle Training and Research Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Neselioglu","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Ankara City Hospital, Ankara, Turkey"},{"name":"Department of Clinical Biochemistry, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozcan","family":"Erel","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Ankara City Hospital, Ankara, Turkey"},{"name":"Department of Clinical Biochemistry, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis.","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","article-title":"Peripheral oxidative stress in relapsing-remitting multiples clerosis.","volume":"45","author":"Tassed","year":"2012","journal-title":"Clin Biochem"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth.","volume":"8","author":"Saher","year":"2005","journal-title":"Nat Neurosci"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"43410","DOI":"10.1038\/srep43410","article-title":"Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.","volume":"7","author":"Jorissen","year":"2017","journal-title":"Sci Rep"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/1947-2714.103310","article-title":"Antioxidant and antiinflammatory role of paraoxonase 1: implication in arteriosclerosis diseases.","volume":"4","author":"Litvinov","year":"2012","journal-title":"N Am J Med Sci"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNR.0000000000000948","article-title":"Inhibition of myeloperoxidase by N-acetyl lysyltyrosylcysteine amide reduces experimental autoimmune encephalomyelitis-induced injury and promotes oligodendrocyte regeneration and neurogenesis in a murine model of progressive multiple sclerosis.","volume":"29","author":"Yu","year":"2018","journal-title":"Neuroreport"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/tx9003775","article-title":"Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.","volume":"23","author":"Shao","year":"2010","journal-title":"Chem Res Toxicol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/0929867325666180530110543","article-title":"Biological consequences of dysfunctional HDL.","volume":"26","author":"Pirillo","year":"2019","journal-title":"Curr Med Chem"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.msard.2015.10.005","article-title":"Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.","volume":"5","author":"Zhornitsky","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/PROM.S148387","article-title":"Comorbidity in US patients with multiple sclerosis.","volume":"9","author":"Edwards","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system.","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6100","article-title":"A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models.","volume":"6","author":"Richards","year":"2002","journal-title":"Health Technol Assess"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ajo.2005.01.031","article-title":"Evolving management of optic neuritis and multiple sclerosis.","volume":"139","author":"Arnold","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21474","article-title":"Axonal loss and myelin in early ON loss in postacute optic neuritis.","volume":"64","author":"Klistorner","year":"2008","journal-title":"Ann Neurol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/brain\/124.3.468","article-title":"Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study.","volume":"124","author":"Brusa","year":"2001","journal-title":"Brain"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00415-004-0477-1","article-title":"Visual recovery following acute optic neuritis a clinical, electrophysiological and magnetic resonance imaging study.","volume":"251","author":"Hickman","year":"2004","journal-title":"J Neurol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/WNL.40.6.919","article-title":"Optic neuritis: a prospective study.","volume":"40","author":"Celesia","year":"1990","journal-title":"Neurology"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2014.03.009","article-title":"Serum myeloperoxidase\/paraoxonase-1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.","volume":"234","author":"Haraguchi","year":"2014","journal-title":"Atherosclerosis"},{"key":"R20-20250503","first-page":"365","article-title":"Association between HDL particles size and myeloperoxidase\/paraoxonase-1 (MPO\/PON1) ratio in patients with acute coronary syndrome.","volume":"51","author":"Razavi","year":"2013","journal-title":"Acta Med Iran"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"109030","DOI":"10.1016\/j.abb.2021.109030","article-title":"Carbohydrate and lipid metabolism in multiple sclerosis: clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy.","volume":"712","author":"Pashaei","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1155\/2013\/567162","article-title":"New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging.","volume":"34","author":"Palavra","year":"2013","journal-title":"Dis Markers"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"101415","DOI":"10.1016\/j.msard.2019.101415","article-title":"The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.","volume":"36","author":"Noori","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacl.2019.06.003","article-title":"High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: a fatigue-metabolism nexus?","volume":"13","author":"Browne","year":"2019","journal-title":"J Clin Lipidol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-8-127","article-title":"Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.","volume":"8","author":"Weinstock-Guttman","year":"2011","journal-title":"J Neuroinflammation"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"12641271","DOI":"10.1111\/ene.12162","article-title":"Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis.","volume":"20","author":"Kardys","year":"2013","journal-title":"Eur J Neurol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"25616","DOI":"10.1074\/jbc.M000955200","article-title":"Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction.","volume":"275","author":"Gotthardt","year":"2000","journal-title":"J Biol Chem"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"25625","DOI":"10.1074\/jbc.M004119200","article-title":"The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and- 2.","volume":"275","author":"Stockinger","year":"2000","journal-title":"J Biol Chem"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0005-2760(94)00232-N","article-title":"Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid.","volume":"1255","author":"Borghini","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.1990440","article-title":"Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogen esis.","volume":"251","author":"Cybulsky","year":"1991","journal-title":"Science"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"H689","DOI":"10.1152\/ajpheart.00962.2008","article-title":"CD40\/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.","volume":"296","author":"Stokes","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1179\/016164106X98080","article-title":"Multiple sclerosis as a vascular disease.","volume":"28","author":"Minagar","year":"2006","journal-title":"Neurol Res"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1194\/jlr.M060970","article-title":"Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.","volume":"56","author":"Fellows","year":"2015","journal-title":"J Lipid Res"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0306-9877(92)90121-R","article-title":"The role of reactive oxygen species in the pathogenesis of multiple sclerosis.","volume":"39","author":"LeVine","year":"1992","journal-title":"Med Hypotheses"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1194\/jlr.M500281-JLR200","article-title":"Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.","volume":"47","author":"Blatter Garin","year":"2006","journal-title":"J Lipid Res"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/1352458505ms1240oa","article-title":"Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity.","volume":"11","author":"Ferretti","year":"2005","journal-title":"Mult Scler"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1352458508098371","article-title":"Paraoxonase 1 activity in different types of multiple sclerosis.","volume":"15","author":"Jamroz-Wisniewska","year":"2009","journal-title":"Mult Scler"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:01:55Z","timestamp":1746316915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037115","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}